MDSCs isolated from the peripheral blood of patients with bladder cancer or melanoma were treated for 48 h with PLX51107, leading to a 1.5-fold increase of annexin V+ MDSCs (Figure 4, F and G; P < 0.0001 for melanoma, P < 0.01 for bladder cancer). Here, ANXA5 is linked to urinary bladder carcinoma.